BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16710033)

  • 1. Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.
    Tsimberidou AM; O'Brien S; Khouri I; Giles FJ; Kantarjian HM; Champlin R; Wen S; Do KA; Smith SC; Lerner S; Freireich EJ; Keating MJ
    J Clin Oncol; 2006 May; 24(15):2343-51. PubMed ID: 16710033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Richter syndrome: biology, incidence, and therapeutic strategies.
    Tsimberidou AM; Keating MJ
    Cancer; 2005 Jan; 103(2):216-28. PubMed ID: 15578683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Richter's transformation in chronic lymphocytic leukemia.
    Tsimberidou AM; Keating MJ; Wierda WG
    Curr Hematol Malig Rep; 2007 Oct; 2(4):265-71. PubMed ID: 20425379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
    Tadmor T; Shvidel L; Bairey O; Goldschmidt N; Ruchlemer R; Fineman R; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A;
    Am J Hematol; 2014 Nov; 89(11):E218-22. PubMed ID: 25110869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Richter's transformation in chronic lymphocytic leukemia.
    Tsimberidou AM; Keating MJ
    Semin Oncol; 2006 Apr; 33(2):250-6. PubMed ID: 16616072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Richter's transformation in chronic lymphocytic leukemia.
    Jain P; O'Brien S
    Oncology (Williston Park); 2012 Dec; 26(12):1146-52. PubMed ID: 23413591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation.
    Cwynarski K; van Biezen A; de Wreede L; Stilgenbauer S; Bunjes D; Metzner B; Koza V; Mohty M; Remes K; Russell N; Nagler A; Scholten M; de Witte T; Sureda A; Dreger P
    J Clin Oncol; 2012 Jun; 30(18):2211-7. PubMed ID: 22547610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China.
    Li Z; Li F; Yi S; Gu Z; Yu Z; Xu Y; Feng X; Liu W; Zou D; Qi J; Zhan F; Qiu L
    BMC Cancer; 2015 Jul; 15():555. PubMed ID: 26219471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Richter's syndrome after allogeneic stem cell transplantation for chronic lymphocytic leukaemia successfully treated by withdrawal of immunosuppression, and donor lymphocyte infusion.
    Español I; Büchler T; Ferrá C; Gallardo D; Reyes P; Sarrá J; Domingo A; Romagosa V; Grañena A
    Bone Marrow Transplant; 2003 Feb; 31(3):215-8. PubMed ID: 12621484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
    Khouri IF; Keating M; Körbling M; Przepiorka D; Anderlini P; O'Brien S; Giralt S; Ippoliti C; von Wolff B; Gajewski J; Donato M; Claxton D; Ueno N; Andersson B; Gee A; Champlin R
    J Clin Oncol; 1998 Aug; 16(8):2817-24. PubMed ID: 9704734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure.
    Rozovski U; Benjamini O; Jain P; Thompson PA; Wierda WG; O'Brien S; Burger JA; Ferrajoli A; Faderl S; Shpall E; Hosing C; Khouri IF; Champlin R; Keating MJ; Estrov Z
    J Clin Oncol; 2015 May; 33(14):1557-63. PubMed ID: 25847930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study.
    Burger JA; Keating MJ; Wierda WG; Hartmann E; Hoellenriegel J; Rosin NY; de Weerdt I; Jeyakumar G; Ferrajoli A; Cardenas-Turanzas M; Lerner S; Jorgensen JL; Nogueras-González GM; Zacharian G; Huang X; Kantarjian H; Garg N; Rosenwald A; O'Brien S
    Lancet Oncol; 2014 Sep; 15(10):1090-9. PubMed ID: 25150798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
    Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
    Tsimberidou AM; Wierda WG; Plunkett W; Kurzrock R; O'Brien S; Wen S; Ferrajoli A; Ravandi-Kashani F; Garcia-Manero G; Estrov Z; Kipps TJ; Brown JR; Fiorentino A; Lerner S; Kantarjian HM; Keating MJ
    J Clin Oncol; 2008 Jan; 26(2):196-203. PubMed ID: 18182662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center.
    Tsimberidou AM; Wen S; O'Brien S; McLaughlin P; Wierda WG; Ferrajoli A; Faderl S; Manning J; Lerner S; Mai CV; Rodriguez AM; Hess M; Do KA; Freireich EJ; Kantarjian HM; Medeiros LJ; Keating MJ
    J Clin Oncol; 2007 Oct; 25(29):4648-56. PubMed ID: 17925562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
    Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
    Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.
    Tsimberidou AM; O'Brien S; Kantarjian HM; Koller C; Hagemeister FB; Fayad L; Lerner S; Bueso-Ramos CE; Keating MJ
    Cancer; 2006 Sep; 107(6):1294-302. PubMed ID: 16902984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
    Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.